HLN

Haleon plc
NYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$40.22B
P/E Ratio
18.67
EPS
$0.49
Beta
0.29
52W High
$11.06
52W Low
$8.38
50-Day MA
$9.45
200-Day MA
$9.75
Dividend Yield
2.16%
Profit Margin
14.50%
Forward P/E
15.13
PEG Ratio
2.07

About Haleon plc

Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline, dedicated to providing innovative health solutions through a robust portfolio of trusted brands, including Sensodyne, Panadol, and Voltaren. Focused on key segments such as oral care, pain relief, and dietary supplements, Haleon addresses evolving consumer needs while leveraging strong brand equity for sustained market presence. The company's commitment to sustainability and ongoing innovation, alongside strategic investments in product development, positions Haleon favorably for long-term growth and enhanced health outcomes, ultimately maximizing value for shareholders.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$11.15B
Gross Profit (TTM)$7.31B
EBITDA$2.85B
Operating Margin23.90%
Return on Equity10.10%
Return on Assets5.08%
Revenue/Share (TTM)$2.50
Book Value$4.94
Price-to-Book1.83
Price-to-Sales (TTM)3.61
EV/Revenue3.349
EV/EBITDA13.30
Quarterly Earnings Growth (YoY)-4.50%
Quarterly Revenue Growth (YoY)2.20%
Shares Outstanding$4.40B
Float$4.43B
% Insiders0.03%
% Institutions14.10%

Historical Volatility

HV 10-Day
83.62%
HV 20-Day
62.98%
HV 30-Day
53.00%
HV 60-Day
40.11%
HV Rank
99.2%

Volatility is currently expanding

Analyst Ratings

Consensus ($10.40 target)
3
Strong Buy
1
Buy
1
Hold

Latest News

ASAIY or HLN: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Consumer Products - Discretionary sector might want to consider either Sendas Distribuidora S.A. Sponsored ADR (ASAIY) or Haleon PLC Sponsored ADR (HLN).

Zacks Investment Research10/29/2026Neutral
UBS says early flu pick-up could lift 2027 earnings at Reckitt and Haleon

UBS, the Swiss investment bank, says an early rise in flu incidence could lift 2027 earnings forecasts for Reckitt Benckiser Group PLC (LSE:RKT, OTCQX:RBGLY), the consumer goods group, and Haleon, the consumer health group. The bank rates Reckitt 'buy' with a price target of 7,600p, implying 39% upside from its Monday closing price of 5,484p.

Proactive Investors10/20/2026Positive
Only Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't Ignore

Nostalgia-fueled experience introduces Excedrin Rapid Relief, providing fast relief of tough pain that starts in as little as 15 minutes Key Takeaways: Excedrin is introducing My Little Headache, a nostalgic digital-pet experience inspired by the handheld toys of the late '90s and early 2000s, capitalizing on the renewed popularity of digital pets among nostalgia-seeking consumers The interactive experience turns headache disruption into a playful, hard-to-ignore virtual pet that escalates through alerts, animations, and reactions As the digital pet becomes increasingly demanding, My Little Headache reminds consumers that headaches do not wait, and neither should relief. With Excedrin Rapid Relief's patented Fast Release Technology starting to provide relief in as little as 15 minutes, the pet transforms alongside the experience, playfully bringing to life the feeling of leaving headache pain behind and getting back to yourself Singer and actor Jesse McCartney helps bridge nostalgia and contemporary culture, reconnecting with longtime fans while building relevance with a new generation WARREN, N.J.

PRNewsWire10/12/2026Neutral
Unilever on JP Morgan positive watch as Haleon faces caution

Unilever PLC (LSE:ULVR) is on JP Morgan's 'positive watch', and Haleon PLC (LSE:HLN, NYSE:HLN) on 'negative watch', ahead of third-quarter reporting by European consumer staples companies. The note adds Givaudan to positive watch alongside Unilever, Heineken N.V.

Proactive Investors10/5/2026Positive
LCUT vs. HLN: Which Stock Is the Better Value Option?

Investors interested in stocks from the Consumer Products - Discretionary sector have probably already heard of Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research9/28/2026Positive
Haleon tipped to cut sales growth guidance as cough and cold season clouds outlook

Haleon PLC (LSE:HLN, NYSE:HLN), the consumer healthcare group, is expected to reduce its 2026 organic sales growth guidance after UBS forecast a subdued third quarter and limited visibility over the cough and cold season. UBS expects Haleon to report organic sales growth of 3.1% for the three months to September, below Visible Alpha consensus of 3.5% and broadly unchanged from the second quarter.

Proactive Investors9/25/2026Negative
Deutsche Bank stays bearish on Haleon as growth headwinds mount

Deutsche Bank has reiterated its 'sell' rating on Haleon PLC (LSE:HLN, NYSE:HLN), warning that the consumer health group faces persistent pressure on growth even as it heads into the cold and flu season. The broker kept a 320p price target on the FTSE 100 company, whose brands include Sensodyne and Panadol, against a last close of 342.8p.

Proactive Investors9/23/2026Negative
LCUT or HLN: Which Is the Better Value Stock Right Now?

Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research9/11/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HLN and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026